Description: Zenrelia is a JAK-inhibitor, that is highly rated by vets and pet owners, for the control of pruritus associated with allergic dermatitis and control of atopic dermatitis in dogs at least 12 months of age. Zenrelia is a flavorless, oral tablet given once daily with or without food, from the comfort of home.
Indications
Zenrelia is a prescription medication used to control itching and inflammation associates with skin allergies for dogs over 12 months of age.
IMPORTANT SAFETY INFORMATION
See package insert including the Boxed Warning. For full prescribing information speak with your veterinarian, call 1-888-545-5973, or visit www.elancolabels.com⁄us⁄zenrelia.
WARNING: VACCINE-INDUCED DISEASE AND INADEQUATE IMMUNE RESPONSE TO VACCINES. Based on results of the vaccine response study, dogs receiving Zenrelia are at risk of fatal vaccine-induced disease and inadequate immune response to vaccines. Dogs should not take Zenrelia for a time period before and after vaccination. Discuss your dog's vaccine schedule with your veterinarian. Dogs should be up to date on vaccinations prior to starting Zenrelia. Do not use in dogs less than 12 months old or with a serious infection. Dogs should be monitored for the development of infections because Zenrelia may increase the chances of developing an infection. Neoplastic conditions (benign and malignant) were observed during clinical studies. The most common side effects were vomiting, diarrhea and tiredness. Zenrelia has not been tested in dogs used for breeding, pregnant, or lactating dogs and has not been evaluated in combination with glucocorticoids, cyclosporine, or other immune suppressive drugs.
Intended For: Dogs
Pet Weight: 23 months of age or older
Includes: 4.8mg, 6.4mg, 8.5mg, 15mg in 1ct, 30ct & 90ct
Health Considerations: Dogs younger than 12 months of age, dogs with serious infections. Zenrelia has not been tested in dogs used for breeding, pregnant, or nursing dogs and has not been evaluated when used with drugs that may effect the immune system. See package insert including the Boxed Warning. For full prescribing information speak with your veterinarian, call 1 888 545 5973 or visit www.elancolabels.com⁄us⁄zenrelia.
Ingredients: ilunocitinib
Use: Innovative treatment, with once daily dosing from the start. Works fast, visible improvements from day one. Continuous Efficacy: No rebound itch due to changing doses. In a head to head clinical trial with Apoquel, 77% of Zenrelia-treated dogs achieved PVAS <2 compared to 53% of Apoquel-treated dogs. Reduces inflammation and improves skin lesions.